As of 2025-09-16, the EV/EBITDA ratio of Cytosorbents Corp (CTSO) is -4.38. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CTSO's latest enterprise value is 61.62 mil USD. CTSO's TTM EBITDA according to its financial statements is -14.07 mil USD. Dividing these 2 quantities gives us the above CTSO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 19.4x - 22.8x | 21.4x |
| Forward P/E multiples | 22.2x - 22.5x | 22.4x |
| Fair Price | (5.04) - (5.11) | (4.97) |
| Upside | -650.4% - -657.8% | -643.0% |
| Date | EV/EBITDA |
| 2025-09-15 | -4.37 |
| 2025-09-12 | -4.48 |
| 2025-09-11 | -4.55 |
| 2025-09-10 | -4.51 |
| 2025-09-09 | -4.75 |
| 2025-09-08 | -4.68 |
| 2025-09-05 | -4.60 |
| 2025-09-04 | -4.65 |
| 2025-09-03 | -4.67 |
| 2025-09-02 | -4.54 |
| 2025-08-29 | -4.51 |
| 2025-08-28 | -4.47 |
| 2025-08-27 | -4.45 |
| 2025-08-26 | -4.45 |
| 2025-08-25 | -4.34 |
| 2025-08-22 | -4.37 |
| 2025-08-21 | -4.06 |
| 2025-08-20 | -4.28 |
| 2025-08-19 | -5.11 |
| 2025-08-18 | -5.20 |
| 2025-08-15 | -5.47 |
| 2025-08-14 | -5.38 |
| 2025-08-13 | -5.11 |
| 2025-08-12 | -5.03 |
| 2025-08-11 | -5.65 |
| 2025-08-08 | -4.76 |
| 2025-08-07 | -4.28 |
| 2025-08-06 | -4.32 |
| 2025-08-05 | -4.38 |
| 2025-08-04 | -4.36 |
| 2025-08-01 | -4.17 |
| 2025-07-31 | -4.09 |
| 2025-07-30 | -4.40 |
| 2025-07-29 | -4.36 |
| 2025-07-28 | -4.50 |
| 2025-07-25 | -4.51 |
| 2025-07-24 | -4.76 |
| 2025-07-23 | -4.85 |
| 2025-07-22 | -4.76 |
| 2025-07-21 | -4.94 |
| 2025-07-18 | -4.89 |
| 2025-07-17 | -4.71 |
| 2025-07-16 | -4.94 |
| 2025-07-15 | -4.89 |
| 2025-07-14 | -4.98 |
| 2025-07-11 | -5.03 |
| 2025-07-10 | -5.38 |
| 2025-07-09 | -5.25 |
| 2025-07-08 | -4.98 |
| 2025-07-07 | -4.89 |